These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22553846)

  • 1. [Expressions of breast cancer metastasis suppressor-1 and heparanase in primary hepatocellular carcinoma and chronic liver diseases and the clinicopathological significances].
    Zeng XB; Yang ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):870-2. PubMed ID: 22553846
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.
    El-Assal ON; Yamanoi A; Ono T; Kohno H; Nagasue N
    Clin Cancer Res; 2001 May; 7(5):1299-305. PubMed ID: 11350898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
    Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
    Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of heparanase mRNA and its clinical significance in primary hepatocellular carcinoma].
    Zhang YL; Fu ZR; Ding GS; Fu H; Wang YH; Wang Q
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):359-61. PubMed ID: 12921566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
    Iavarone M; Lampertico P; Seletti C; Francesca Donato M; Ronchi G; del Ninno E; Colombo M
    Cancer; 2003 Aug; 98(3):529-34. PubMed ID: 12879470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma.
    Ma S; Guan XY; Lee TK; Chan KW
    Hum Pathol; 2007 Aug; 38(8):1201-6. PubMed ID: 17442377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron in NASH, chronic liver diseases and HCC: how much iron is too much?
    Pietrangelo A
    J Hepatol; 2009 Feb; 50(2):249-51. PubMed ID: 19070915
    [No Abstract]   [Full Text] [Related]  

  • 9. [The expression of Tec and the level of its phosphorylation in primary hepatic carcinomas].
    Chen C; Wang G; Zhang ZM; Xu W; Li Q; Hu Q; Wang D; Li ZP; Yang ZX; Suo JY; Zheng JJ; Wang HZ
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):910-3. PubMed ID: 18171525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
    Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
    Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma.
    Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
    J Surg Oncol; 2002 Nov; 81(3):148-54; disscusion 154. PubMed ID: 12407728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues.
    Sakemi R; Yano H; Ogasawara S; Akiba J; Nakashima O; Fukahori S; Sata M; Kojiro M
    Oncol Rep; 2007 Jul; 18(1):65-70. PubMed ID: 17549347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma.
    Zhang Y; Li L; Wang Y; Zhang J; Wei G; Sun Y; Shen F
    Biochem Biophys Res Commun; 2007 Jun; 358(1):124-9. PubMed ID: 17467664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma and liver pathology in tonga.
    Finau SA
    N Z Med J; 1981 Jan; 93(675):5-8. PubMed ID: 6259565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry DNA content and morphobiological characteristics in chronic and neoplastic human liver disease.
    Paradiso A; Barletta A; Prete F; Pellecchia A; Romagno D; Lucchese G; Benvestito V; Zito FA; Russo S; De Lena M
    Ital J Gastroenterol; 1995; 27(1):8-12. PubMed ID: 7795288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].
    Xiang X; Zhao WB; Wang X
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):661-4. PubMed ID: 19785952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between heparanase mRNA expression in human gastric cancer and its clinicopathological features].
    Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Chen ZX; Huang YH; Cai SR
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):609-11. PubMed ID: 15634522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histology-directed matrix-assisted laser desorption/ionization analysis reveals tissue origin and p53 status of primary liver cancers.
    Jeon YE; Lee SC; Paik SS; Lee KG; Jin SY; Kim HR; Yoo CW; Park HM; Han SY; Choi DH; Kim HK
    Pathol Int; 2011 Aug; 61(8):449-55. PubMed ID: 21790858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fascin and cortactin expression is correlated with a poor prognosis in hepatocellular carcinoma.
    Huang X; Ji J; Xue H; Zhang F; Han X; Cai Y; Zhang J; Ji G
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):633-9. PubMed ID: 22495401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions.
    Grigioni WF; Fiorentino M; D'Errico A; Ponzetto A; Crepaldi T; Prat M; Comoglio PM
    Hepatology; 1995 Jun; 21(6):1543-6. PubMed ID: 7768498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.